CT-based radiomic signatures for prediction of pathologic complete response in esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy
The objective of this study was to build models to predict complete pathologic response (pCR) after neoadjuvant chemoradiotherapy (nCRT) in esophageal squamous cell carcinoma (ESCC) patients using radiomic features. A total of 55 consecutive patients pathologically diagnosed as having ESCC were incl...
Saved in:
Published in | Journal of radiation research Vol. 60; no. 4; pp. 538 - 545 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Oxford University Press
01.07.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The objective of this study was to build models to predict complete pathologic response (pCR) after neoadjuvant chemoradiotherapy (nCRT) in esophageal squamous cell carcinoma (ESCC) patients using radiomic features. A total of 55 consecutive patients pathologically diagnosed as having ESCC were included in this study. Patients were divided into a training cohort (44 patients) and a testing cohort (11 patients). The logistic regression analysis using likelihood ratio forward selection was performed to select the predictive clinical parameters for pCR, and the least absolute shrinkage and selection operator (LASSO) with logistic regression to select radiomic predictors in the training cohort. Model performance in the training and testing groups was evaluated using the area under the receiver operating characteristic curves (AUC). The multivariate logistic regression analysis identified no clinical predictors for pCR. Thus, only radiomic features selected by LASSO were used to build prediction models. Three logistic regression models for pCR prediction were developed in the training cohort, and they were able to predict pCR well in both the training (AUC, 0.84–0.86) and the testing cohorts (AUC, 0.71–0.79). There were no differences between these AUCs. We developed three predictive models for pCR after nCRT using radiomic parameters and they demonstrated good model performance. |
---|---|
AbstractList | The objective of this study was to build models to predict complete pathologic response (pCR) after neoadjuvant chemoradiotherapy (nCRT) in esophageal squamous cell carcinoma (ESCC) patients using radiomic features. A total of 55 consecutive patients pathologically diagnosed as having ESCC were included in this study. Patients were divided into a training cohort (44 patients) and a testing cohort (11 patients). The logistic regression analysis using likelihood ratio forward selection was performed to select the predictive clinical parameters for pCR, and the least absolute shrinkage and selection operator (LASSO) with logistic regression to select radiomic predictors in the training cohort. Model performance in the training and testing groups was evaluated using the area under the receiver operating characteristic curves (AUC). The multivariate logistic regression analysis identified no clinical predictors for pCR. Thus, only radiomic features selected by LASSO were used to build prediction models. Three logistic regression models for pCR prediction were developed in the training cohort, and they were able to predict pCR well in both the training (AUC, 0.84-0.86) and the testing cohorts (AUC, 0.71-0.79). There were no differences between these AUCs. We developed three predictive models for pCR after nCRT using radiomic parameters and they demonstrated good model performance. The objective of this study was to build models to predict complete pathologic response (pCR) after neoadjuvant chemoradiotherapy (nCRT) in esophageal squamous cell carcinoma (ESCC) patients using radiomic features. A total of 55 consecutive patients pathologically diagnosed as having ESCC were included in this study. Patients were divided into a training cohort (44 patients) and a testing cohort (11 patients). The logistic regression analysis using likelihood ratio forward selection was performed to select the predictive clinical parameters for pCR, and the least absolute shrinkage and selection operator (LASSO) with logistic regression to select radiomic predictors in the training cohort. Model performance in the training and testing groups was evaluated using the area under the receiver operating characteristic curves (AUC). The multivariate logistic regression analysis identified no clinical predictors for pCR. Thus, only radiomic features selected by LASSO were used to build prediction models. Three logistic regression models for pCR prediction were developed in the training cohort, and they were able to predict pCR well in both the training (AUC, 0.84-0.86) and the testing cohorts (AUC, 0.71-0.79). There were no differences between these AUCs. We developed three predictive models for pCR after nCRT using radiomic parameters and they demonstrated good model performance.The objective of this study was to build models to predict complete pathologic response (pCR) after neoadjuvant chemoradiotherapy (nCRT) in esophageal squamous cell carcinoma (ESCC) patients using radiomic features. A total of 55 consecutive patients pathologically diagnosed as having ESCC were included in this study. Patients were divided into a training cohort (44 patients) and a testing cohort (11 patients). The logistic regression analysis using likelihood ratio forward selection was performed to select the predictive clinical parameters for pCR, and the least absolute shrinkage and selection operator (LASSO) with logistic regression to select radiomic predictors in the training cohort. Model performance in the training and testing groups was evaluated using the area under the receiver operating characteristic curves (AUC). The multivariate logistic regression analysis identified no clinical predictors for pCR. Thus, only radiomic features selected by LASSO were used to build prediction models. Three logistic regression models for pCR prediction were developed in the training cohort, and they were able to predict pCR well in both the training (AUC, 0.84-0.86) and the testing cohorts (AUC, 0.71-0.79). There were no differences between these AUCs. We developed three predictive models for pCR after nCRT using radiomic parameters and they demonstrated good model performance. |
Author | He, Binghui Yang, Zhining Lin, Zhixiong Li, Mei Luo, Ren Wang, Dandan Gao, Xiaoying Zhuang, Xinyu |
AuthorAffiliation | 2 Department of Radiation Oncology, Donghua Hospital Affiliated to Zhongshan University,1 Dongcheng East Road, Dongguan, Guangdong, China 1 Department of Radiation Oncology, Cancer Hospital of Shantou University Medical College, 7 Raoping Road, Shantou, Guangdong, China 4 Department of Radiation Oncology, Medical Center—University of Freiburg, Robert-Koch-Str. 3, Freiburg, Germany 3 Eye Center, Medical Center—University of Freiburg, Killianstraße, Freiburg Germany 5 Faculty of Biology, University of Freiburg, Freiburg, Germany |
AuthorAffiliation_xml | – name: 2 Department of Radiation Oncology, Donghua Hospital Affiliated to Zhongshan University,1 Dongcheng East Road, Dongguan, Guangdong, China – name: 4 Department of Radiation Oncology, Medical Center—University of Freiburg, Robert-Koch-Str. 3, Freiburg, Germany – name: 1 Department of Radiation Oncology, Cancer Hospital of Shantou University Medical College, 7 Raoping Road, Shantou, Guangdong, China – name: 5 Faculty of Biology, University of Freiburg, Freiburg, Germany – name: 3 Eye Center, Medical Center—University of Freiburg, Killianstraße, Freiburg Germany |
Author_xml | – sequence: 1 givenname: Zhining surname: Yang fullname: Yang, Zhining organization: Department of Radiation Oncology, Cancer Hospital of Shantou University Medical College, 7 Raoping Road, Shantou, Guangdong, China – sequence: 2 givenname: Binghui surname: He fullname: He, Binghui organization: Department of Radiation Oncology, Cancer Hospital of Shantou University Medical College, 7 Raoping Road, Shantou, Guangdong, China, Department of Radiation Oncology, Donghua Hospital Affiliated to Zhongshan University,1 Dongcheng East Road, Dongguan, Guangdong, China – sequence: 3 givenname: Xinyu surname: Zhuang fullname: Zhuang, Xinyu organization: Eye Center, Medical Center—University of Freiburg, Killianstraße, Freiburg Germany – sequence: 4 givenname: Xiaoying surname: Gao fullname: Gao, Xiaoying organization: Department of Radiation Oncology, Cancer Hospital of Shantou University Medical College, 7 Raoping Road, Shantou, Guangdong, China – sequence: 5 givenname: Dandan surname: Wang fullname: Wang, Dandan organization: Department of Radiation Oncology, Cancer Hospital of Shantou University Medical College, 7 Raoping Road, Shantou, Guangdong, China – sequence: 6 givenname: Mei surname: Li fullname: Li, Mei organization: Department of Radiation Oncology, Cancer Hospital of Shantou University Medical College, 7 Raoping Road, Shantou, Guangdong, China – sequence: 7 givenname: Zhixiong surname: Lin fullname: Lin, Zhixiong organization: Department of Radiation Oncology, Cancer Hospital of Shantou University Medical College, 7 Raoping Road, Shantou, Guangdong, China – sequence: 8 givenname: Ren orcidid: 0000-0001-9508-5497 surname: Luo fullname: Luo, Ren organization: Department of Radiation Oncology, Medical Center—University of Freiburg, Robert-Koch-Str. 3, Freiburg, Germany, Faculty of Biology, University of Freiburg, Freiburg, Germany |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31111948$$D View this record in MEDLINE/PubMed |
BookMark | eNptktuKFDEQhoOsuAe98QEk4I0I41Y66UNuBBk8wYI363WoSVfPZOhOepP0wvoevq8ZZ1d0MTcJ5Ku__qL-c3bigyfGXgp4J0DLy32MlzH-gKp9ws6EVHqlRd2esDNQ5S2hgVN2ntIeCgE1PGOnUpSjVXfGfq6vVxtM1POIvQuTszy5rce8REp8CJHPkXpnswueh4HPmHdhDNvC2TDNI2XihZyDT8Sd55TCvMMt4cjTzYJTWBK3NI7cYrTOhwk5Dpki9xSw3y-36DO3O5rC7_55RxHnu-fs6YBjohf39wX7_unj9frL6urb56_rD1crq3STV4OSommtJGh0q0SnoNU19J1SgFYNVAvZNfVm0-pBtZWqJVQ1VqD0UHV1VZG8YO-PuvOymai35HPE0czRTRjvTEBn_v3xbme24dY0jQINbRF4cy8Qw81CKZvJpcO8WOZbkqkqWUHTSt0V9PUjdB-W6Mt4RooWGqmEFoV69bejP1YeNlYAOAI2hpQiDca6jIf1FINuNALMIRSmhMIcQ1FK3j4qeVD9D_wLH4i87A |
CitedBy_id | crossref_primary_10_1088_1361_6560_abac9c crossref_primary_10_1245_s10434_022_12207_7 crossref_primary_10_3390_ijms20235825 crossref_primary_10_3390_biomedicines11113072 crossref_primary_10_1186_s40644_024_00659_x crossref_primary_10_1186_s12967_024_05392_4 crossref_primary_10_1259_bjr_20210934 crossref_primary_10_1001_jamanetworkopen_2020_15927 crossref_primary_10_3389_fonc_2024_1347650 crossref_primary_10_3390_cancers13102469 crossref_primary_10_1007_s00330_023_10040_4 crossref_primary_10_3389_fonc_2024_1350914 crossref_primary_10_3389_fonc_2023_1089365 crossref_primary_10_1007_s00261_023_03938_6 crossref_primary_10_3389_fonc_2020_615167 crossref_primary_10_1016_j_tranon_2023_101804 crossref_primary_10_3748_wjg_v27_i36_6110 crossref_primary_10_1016_j_clbc_2020_12_004 crossref_primary_10_3748_wjg_v28_i42_6002 crossref_primary_10_1016_j_ctro_2022_01_003 crossref_primary_10_1186_s40364_023_00480_x crossref_primary_10_3389_fonc_2023_1131883 crossref_primary_10_1007_s00330_020_07439_8 crossref_primary_10_1016_j_radonc_2022_06_010 crossref_primary_10_3390_diagnostics11061049 crossref_primary_10_1016_j_ejso_2024_108450 crossref_primary_10_1016_j_pharmthera_2024_108591 crossref_primary_10_1186_s12885_024_12239_0 crossref_primary_10_1002_acm2_13434 crossref_primary_10_1038_s41598_024_81237_w crossref_primary_10_3390_diagnostics12051070 crossref_primary_10_3389_fonc_2023_1162238 crossref_primary_10_3389_fimmu_2024_1405146 crossref_primary_10_1186_s13244_024_01851_0 crossref_primary_10_1186_s13014_021_01925_z crossref_primary_10_3389_fonc_2023_1082960 crossref_primary_10_3389_fonc_2020_01398 crossref_primary_10_3390_cancers13092145 crossref_primary_10_1038_s41598_024_52418_4 crossref_primary_10_1016_j_ejso_2024_108052 crossref_primary_10_4251_wjgo_v14_i3_703 crossref_primary_10_1007_s00423_023_02951_z crossref_primary_10_1016_j_radmp_2023_10_009 crossref_primary_10_1007_s00330_022_08776_6 crossref_primary_10_1186_s13014_020_01692_3 crossref_primary_10_3390_cancers14123035 crossref_primary_10_1016_j_radonc_2020_09_014 crossref_primary_10_1097_JS9_0000000000000441 crossref_primary_10_1007_s00330_023_09884_7 crossref_primary_10_1016_j_ijrobp_2021_06_033 crossref_primary_10_3390_cells12010114 crossref_primary_10_1007_s00330_023_10020_8 crossref_primary_10_1038_s41598_021_92363_0 crossref_primary_10_3389_fonc_2021_739933 crossref_primary_10_1016_j_media_2022_102423 crossref_primary_10_1259_bjro_20190046 crossref_primary_10_1007_s00259_021_05658_9 |
Cites_doi | 10.1016/j.crad.2011.08.012 10.3389/fonc.2016.00072 10.1016/j.radonc.2015.04.028 10.1148/radiol.13122869 10.1093/dote/dox103 10.1093/annonc/mds617 10.1007/s00259-013-2486-8 10.1038/ncomms5006 10.1148/radiol.09091324 10.18637/jss.v033.i01 10.1002/mp.13202 10.1200/JCO.2015.65.9128 10.1186/1477-7819-12-170 10.2307/2531595 10.18637/jss.v039.i05 10.3322/caac.21262 10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C 10.1158/0008-5472.CAN-17-0339 10.1007/s12029-015-9699-y 10.1002/ijc.25516 10.1016/j.jcma.2017.08.007 10.21037/jtd.2017.06.123 10.1148/radiol.2018172229 10.1186/1471-2105-12-77 10.2967/jnumed.110.082404 10.1245/s10434-011-2078-4 10.1111/dote.12170 10.18632/oncotarget.22304 10.1016/j.radonc.2017.07.013 10.1056/NEJMoa1112088 10.1016/j.athoracsur.2008.11.001 10.1088/0031-9155/61/2/906 10.2967/jnumed.115.163766 10.2967/jnumed.113.129858 10.2967/jnumed.114.144055 10.1038/nature20805 |
ContentType | Journal Article |
Copyright | The Author(s) 2019. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Radiation Oncology. The Author(s) 2019. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Radiation Oncology. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2019. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Radiation Oncology. 2019 |
Copyright_xml | – notice: The Author(s) 2019. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Radiation Oncology. – notice: The Author(s) 2019. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Radiation Oncology. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2019. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Radiation Oncology. 2019 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 8AO 8FE 8FG 8FI 8FJ 8FK ABUWG AFKRA ARAPS AZQEC BENPR BGLVJ CCPQU DWQXO FYUFA GHDGH HCIFZ K9. M0S P5Z P62 PHGZM PHGZT PIMPY PKEHL PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM |
DOI | 10.1093/jrr/rrz027 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Technology Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection ProQuest Central Essentials ProQuest Central Technology Collection (via ProQuest SciTech Premium Collection) ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Technology Collection ProQuest One Academic Middle East (New) ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) Advanced Technologies & Aerospace Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Advanced Technologies & Aerospace Database ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE CrossRef Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1349-9157 |
EndPage | 545 |
ExternalDocumentID | PMC6640907 31111948 10_1093_jrr_rrz027 |
Genre | Journal Article |
GroupedDBID | --- -~X .I3 0R~ 29L 2WC 4.4 53G 5GY 5VS 7X7 8AO 8FI 8FJ AAFWJ AAMVS AAOGV AAPXW AAVAP AAWTL AAYXX ABAZT ABEJV ABGNP ABPTD ABQLI ABUWG ABVLG ABWST ABXVV ACGFS ADBBV ADHZD ADMLS AENEX AENZO AFFNX AFKRA AFPKN AGQXC ALMA_UNASSIGNED_HOLDINGS ALUQC AMNDL AOIJS ARAPS BAWUL BAYMD BCNDV BEFXN BENPR BFFAM BGLVJ BGNUA BKEBE BPEOZ CCPQU CIDKT CITATION CS3 DIK DU5 D~K E3Z EBS EJD EMOBN F5P FYUFA GROUPED_DOAJ GX1 H13 HCIFZ HMCUK HYE IAO IHR INH ITC JAVBF JMI JSF JSH KSI M48 ML0 O9- OAWHX OCL OJQWA OK1 OVT O~Y P2P PEELM PHGZM PHGZT PIMPY RNS ROL RPM RXO TOX TR2 UKHRP W2D XSB ~D7 AAPPN BTTYL CGR CUY CVF ECM EIF M~E NPM RHF ROX 3V. 7XB 8FE 8FG 8FK AZQEC DWQXO K9. P62 PKEHL PQEST PQGLB PQQKQ PQUKI PRINS PUEGO 7X8 5PM |
ID | FETCH-LOGICAL-c496t-f43167c3e0697418407950d8440ac4fe513865bb79f472453025a2049f28522e3 |
IEDL.DBID | M48 |
ISSN | 0449-3060 1349-9157 |
IngestDate | Thu Aug 21 18:11:25 EDT 2025 Fri Jul 11 03:21:55 EDT 2025 Sat Aug 23 13:06:12 EDT 2025 Wed Feb 19 02:31:23 EST 2025 Tue Jul 01 03:33:52 EDT 2025 Thu Apr 24 22:53:45 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | complete pathologic response esophageal squamous cell carcinoma neoadjuvant chemoradiotherapy radiomics LASSO |
Language | English |
License | http://creativecommons.org/licenses/by/4.0 The Author(s) 2019. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Radiation Oncology. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c496t-f43167c3e0697418407950d8440ac4fe513865bb79f472453025a2049f28522e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Zhining Yang, Binghui He and Xinyu Zhuang contributed equally to this work. |
ORCID | 0000-0001-9508-5497 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1093/jrr/rrz027 |
PMID | 31111948 |
PQID | 3170634191 |
PQPubID | 1976363 |
PageCount | 8 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6640907 proquest_miscellaneous_2232067398 proquest_journals_3170634191 pubmed_primary_31111948 crossref_citationtrail_10_1093_jrr_rrz027 crossref_primary_10_1093_jrr_rrz027 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-07-01 |
PublicationDateYYYYMMDD | 2019-07-01 |
PublicationDate_xml | – month: 07 year: 2019 text: 2019-07-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Oxford |
PublicationTitle | Journal of radiation research |
PublicationTitleAlternate | J Radiat Res |
PublicationYear | 2019 |
Publisher | Oxford University Press |
Publisher_xml | – name: Oxford University Press |
References | van Hagen (2019071912395326000_rrz027C19) 2012; 366 Mandard (2019071912395326000_rrz027C10) 1994; 73 Dittrick (2019071912395326000_rrz027C5) 2012; 19 Hatt (2019071912395326000_rrz027C16) 2013; 40 van Griethuysen (2019071912395326000_rrz027C21) 2017; 77 van Rossum (2019071912395326000_rrz027C13) 2016; 57 Lin (2019071912395326000_rrz027C4) 2018; 81 Simon (2019071912395326000_rrz027C23) 2011; 39 Toxopeus (2019071912395326000_rrz027C20) 2015; 115 Ferlay (2019071912395326000_rrz027C2) 2010; 127 Zhai (2019071912395326000_rrz027C8) 2017; 124 Yip (2019071912395326000_rrz027C11) 2015; 28 Chao (2019071912395326000_rrz027C33) 2017; 30 Hou (2019071912395326000_rrz027C12) 2017; 8 Donahue (2019071912395326000_rrz027C3) 2009; 87 Huang (2019071912395326000_rrz027C9) 2016; 34 DeLong (2019071912395326000_rrz027C25) 1988; 44 Yip (2019071912395326000_rrz027C18) 2016; 6 Robin (2019071912395326000_rrz027C24) 2011; 12 Orlhac (2019071912395326000_rrz027C31) 2014; 55 Torre (2019071912395326000_rrz027C1) 2015; 65 Beukinga (2019071912395326000_rrz027C14) 2018; 287 Friedman (2019071912395326000_rrz027C22) 2010; 33 Huang (2019071912395326000_rrz027C32) 2014; 12 The Cancer Genome Atlas Research Network (2019071912395326000_rrz027C36) 2017; 541 Kwee (2019071912395326000_rrz027C26) 2010; 254 Hatt (2019071912395326000_rrz027C30) 2015; 56 Soufi (2019071912395326000_rrz027C35) 2018; 45 den Bakker (2019071912395326000_rrz027C7) 2017; 9 Boggs (2019071912395326000_rrz027C34) 2015; 46 Tixier (2019071912395326000_rrz027C15) 2011; 52 Aerts (2019071912395326000_rrz027C6) 2014; 5 Cheedella (2019071912395326000_rrz027C27) 2013; 24 Ganeshan (2019071912395326000_rrz027C28) 2012; 67 Yip (2019071912395326000_rrz027C17) 2016; 61 Yip (2019071912395326000_rrz027C29) 2014; 270 |
References_xml | – volume: 67 start-page: 157 year: 2012 ident: 2019071912395326000_rrz027C28 article-title: Tumour heterogeneity in oesophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival publication-title: Clin Radiol doi: 10.1016/j.crad.2011.08.012 – volume: 6 start-page: 72 year: 2016 ident: 2019071912395326000_rrz027C18 article-title: Relationship between the temporal changes in positron-emission tomography—imaging-based textural features and pathologic response and survival in esophageal cancer patients publication-title: Front Oncol doi: 10.3389/fonc.2016.00072 – volume: 115 start-page: 392 year: 2015 ident: 2019071912395326000_rrz027C20 article-title: Nomogram for predicting pathologically complete response after neoadjuvant chemoradiotherapy for oesophageal cancer publication-title: Radiother Oncol doi: 10.1016/j.radonc.2015.04.028 – volume: 270 start-page: 141 year: 2014 ident: 2019071912395326000_rrz027C29 article-title: Primary esophageal cancer: heterogeneity as potential prognostic biomarker in patients treated with definitive chemotherapy and radiation therapy publication-title: Radiology doi: 10.1148/radiol.13122869 – volume: 30 start-page: 1 year: 2017 ident: 2019071912395326000_rrz027C33 article-title: Development of a nomogram for the prediction of pathological complete response after neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma publication-title: Dis Esophagus doi: 10.1093/dote/dox103 – volume: 24 start-page: 1262 year: 2013 ident: 2019071912395326000_rrz027C27 article-title: Association between clinical complete response and pathological complete response after preoperative chemoradiation in patients with gastroesophageal cancer: analysis in a large cohort publication-title: Ann Oncol doi: 10.1093/annonc/mds617 – volume: 40 start-page: 1662 year: 2013 ident: 2019071912395326000_rrz027C16 article-title: Robustness of intratumour 18F-FDG PET uptake heterogeneity quantification for therapy response prediction in oesophageal carcinoma publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-013-2486-8 – volume: 5 start-page: 4006 year: 2014 ident: 2019071912395326000_rrz027C6 article-title: Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach publication-title: Nat Commun doi: 10.1038/ncomms5006 – volume: 254 start-page: 707 year: 2010 ident: 2019071912395326000_rrz027C26 article-title: Prediction of tumor response to neoadjuvant therapy in patients with esophageal cancer with use of 18F FDG PET: a systematic review publication-title: Radiology doi: 10.1148/radiol.09091324 – volume: 33 start-page: 1 year: 2010 ident: 2019071912395326000_rrz027C22 article-title: Regularization paths for generalized linear models via coordinate descent publication-title: J Stat Softw doi: 10.18637/jss.v033.i01 – volume: 45 start-page: 5116 year: 2018 ident: 2019071912395326000_rrz027C35 article-title: Identification of optimal mother wavelets in survival prediction of lung cancer patients using wavelet decomposition-based radiomic features publication-title: Med Phys doi: 10.1002/mp.13202 – volume: 34 start-page: 2157 year: 2016 ident: 2019071912395326000_rrz027C9 article-title: Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer publication-title: J Clin Oncol doi: 10.1200/JCO.2015.65.9128 – volume: 12 start-page: 170 year: 2014 ident: 2019071912395326000_rrz027C32 article-title: Predictors of pathological complete response to neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma publication-title: World J Surg Oncol doi: 10.1186/1477-7819-12-170 – volume: 44 start-page: 837 year: 1988 ident: 2019071912395326000_rrz027C25 article-title: Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach publication-title: Biometrics doi: 10.2307/2531595 – volume: 39 start-page: 1 year: 2011 ident: 2019071912395326000_rrz027C23 article-title: Regularization paths for Cox’s proportional hazards model via coordinate descent publication-title: J Stat Softw doi: 10.18637/jss.v039.i05 – volume: 65 start-page: 87 year: 2015 ident: 2019071912395326000_rrz027C1 article-title: Global cancer statistics, 2012 publication-title: CA Cancer J Clin doi: 10.3322/caac.21262 – volume: 73 start-page: 2680 year: 1994 ident: 2019071912395326000_rrz027C10 article-title: Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations publication-title: Cancer doi: 10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C – volume: 77 start-page: e104 year: 2017 ident: 2019071912395326000_rrz027C21 article-title: Computational radiomics system to decode the radiographic phenotype publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-17-0339 – volume: 46 start-page: 131 year: 2015 ident: 2019071912395326000_rrz027C34 article-title: Primary gross tumor volume is an important prognostic factor in locally advanced esophageal cancer patients treated with trimodality therapy publication-title: J Gastrointest Cancer doi: 10.1007/s12029-015-9699-y – volume: 127 start-page: 2893 year: 2010 ident: 2019071912395326000_rrz027C2 article-title: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 publication-title: Int J Cancer doi: 10.1002/ijc.25516 – volume: 81 start-page: 18 year: 2018 ident: 2019071912395326000_rrz027C4 article-title: The impact of pathological complete response after neoadjuvant chemoradiotherapy in locally advanced squamous cell carcinoma of esophagus publication-title: J Chin Med Assoc doi: 10.1016/j.jcma.2017.08.007 – volume: 9 start-page: S843 year: 2017 ident: 2019071912395326000_rrz027C7 article-title: Non responders to neoadjuvant chemoradiation for esophageal cancer: why better prediction is necessary publication-title: J Thorac Dis doi: 10.21037/jtd.2017.06.123 – volume: 287 start-page: 983 year: 2018 ident: 2019071912395326000_rrz027C14 article-title: Prediction of response to neoadjuvant chemotherapy and radiation therapy with baseline and restaging 18F-FDG PET imaging biomarkers in patients with esophageal cancer publication-title: Radiology doi: 10.1148/radiol.2018172229 – volume: 12 start-page: 77 year: 2011 ident: 2019071912395326000_rrz027C24 article-title: pROC: an open-source package for R and S+ to analyze and compare ROC curves publication-title: BMC Bioinformatics doi: 10.1186/1471-2105-12-77 – volume: 52 start-page: 369 year: 2011 ident: 2019071912395326000_rrz027C15 article-title: Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer publication-title: J Nucl Med doi: 10.2967/jnumed.110.082404 – volume: 19 start-page: 1678 year: 2012 ident: 2019071912395326000_rrz027C5 article-title: Pathologic nonresponders after neoadjuvant chemoradiation for esophageal cancer demonstrate no survival benefit compared with patients treated with primary esophagectomy publication-title: Ann Surg Oncol doi: 10.1245/s10434-011-2078-4 – volume: 28 start-page: 172 year: 2015 ident: 2019071912395326000_rrz027C11 article-title: Assessment of changes in tumor heterogeneity following neoadjuvant chemotherapy in primary esophageal cancer publication-title: Dis Esophagus doi: 10.1111/dote.12170 – volume: 8 start-page: 104444 year: 2017 ident: 2019071912395326000_rrz027C12 article-title: Radiomic analysis in contrast-enhanced CT: predict treatment response to chemoradiotherapy in esophageal carcinoma publication-title: Oncotarget doi: 10.18632/oncotarget.22304 – volume: 124 start-page: 256 year: 2017 ident: 2019071912395326000_rrz027C8 article-title: Improving the prediction of overall survival for head and neck cancer patients using image biomarkers in combination with clinical parameters publication-title: Radiother Oncol doi: 10.1016/j.radonc.2017.07.013 – volume: 366 start-page: 2074 year: 2012 ident: 2019071912395326000_rrz027C19 article-title: Preoperative chemoradiotherapy for esophageal or junctional cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa1112088 – volume: 87 start-page: 392 year: 2009 ident: 2019071912395326000_rrz027C3 article-title: Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival publication-title: Ann Thorac Surg doi: 10.1016/j.athoracsur.2008.11.001 – volume: 61 start-page: 906 year: 2016 ident: 2019071912395326000_rrz027C17 article-title: Use of registration-based contour propagation in texture analysis for esophageal cancer pathologic response prediction publication-title: Phys Med Biol doi: 10.1088/0031-9155/61/2/906 – volume: 57 start-page: 691 year: 2016 ident: 2019071912395326000_rrz027C13 article-title: The incremental value of subjective and quantitative assessment of 18F-FDG PET for the prediction of pathologic complete response to preoperative chemoradiotherapy in esophageal cancer publication-title: J Nucl Med doi: 10.2967/jnumed.115.163766 – volume: 55 start-page: 414 year: 2014 ident: 2019071912395326000_rrz027C31 article-title: Tumor texture analysis in 18F-FDG PET: relationships between texture parameters, histogram indices, standardized uptake values, metabolic volumes, and total lesion glycolysis publication-title: J Nucl Med doi: 10.2967/jnumed.113.129858 – volume: 56 start-page: 38 year: 2015 ident: 2019071912395326000_rrz027C30 article-title: 18F-FDG PET uptake characterization through texture analysis: investigating the complementary nature of heterogeneity and functional tumor volume in a multi-cancer site patient cohort publication-title: J Nucl Med doi: 10.2967/jnumed.114.144055 – volume: 541 start-page: 169 year: 2017 ident: 2019071912395326000_rrz027C36 article-title: Integrated genomic characterization of oesophageal carcinoma publication-title: Nature doi: 10.1038/nature20805 |
SSID | ssj0027050 |
Score | 2.4687395 |
Snippet | The objective of this study was to build models to predict complete pathologic response (pCR) after neoadjuvant chemoradiotherapy (nCRT) in esophageal squamous... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 538 |
SubjectTerms | Adult Aged Chemoradiotherapy, Adjuvant Chemotherapy Esophageal cancer Esophageal Neoplasms - diagnostic imaging Esophageal Neoplasms - drug therapy Esophageal Neoplasms - radiotherapy Esophageal Squamous Cell Carcinoma - diagnostic imaging Esophageal Squamous Cell Carcinoma - drug therapy Esophageal Squamous Cell Carcinoma - radiotherapy Female Humans Likelihood ratio Logistic Models Male Middle Aged Parameters Prediction models Radiation therapy Radiomics Regression Analysis Regression models Regular Paper Retrospective Studies ROC Curve Squamous cell carcinoma Tomography, X-Ray Computed Treatment Outcome |
SummonAdditionalLinks | – databaseName: ProQuest Technology Collection dbid: 8FG link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9QwELWgCMQFQflaKGgQXDhYm40dZ31CqGKpkODUSr1F_hRb0WSb7B7K_-D_MmNnty0gzrbkKDP2vBmP32PsnZ_FStQmclVFw6UWjhuMDFxKabzQxgafGmS_qaMT-eW0Oh0LbsPYVrk9E9NB7TtHNfKpIJ4XIh-bfVhdcFKNotvVUULjNrszw0hDLV3zxeerhKtICq2FlHS_r4otPakW07O-n_b9z4LUZK4HpL9Q5p_Nkteiz-IhezDCRviY7fyI3QrtPrubhSQv99m9r-MV-WP26_CYU2jy0Bu_pDfHQD0aib9zAISosOppMhkEuggkSZwPQEjt5Qiioc-NswGWLQTSOcBDB1cfLjaGKgVA1X5wpELUducGks44tKEz_myDyHwN6AnnXVo_v--6fMJOFp-OD4_4qL3AndRqzWN6Iu9EKJQmghvM-3RV-LmUhXEyhmpGYqHW1jrKupSkPVSZEtONWM4R0gXxlO21XRueM4hGWlVabyuHHlA7SyqAXsRYSmeVdxP2fmuAxo3E5KSP8aPJF-SiQWM12VgT9nY3d5XpOP4562Brx2bckkNz5UAT9mY3jJuJ_pnBf7QZGsRKRGcv9HzCnmWz75YRFFy0xJH6hkPsJhBR982Rdvk9EXYrhVl0Ub_4_2e9ZPcRjencC3zA9tb9JrxCxLO2r5Nb_wZBQAau priority: 102 providerName: ProQuest |
Title | CT-based radiomic signatures for prediction of pathologic complete response in esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy |
URI | https://www.ncbi.nlm.nih.gov/pubmed/31111948 https://www.proquest.com/docview/3170634191 https://www.proquest.com/docview/2232067398 https://pubmed.ncbi.nlm.nih.gov/PMC6640907 |
Volume | 60 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1Lb9QwEB71IapeKiivlLIygguH0GzsvA4IQdWlQmqFUFfaW-T4IbZqkza7K7H8D_4vM3aydKFccskoljxjzzfO-PsA3uihTXgmbZgmVoai4CqUmBlCIYTUvJCV0a5B9jw9HYsvk2SyAb1-ZzeBs3tLO9KTGrdX737cLj_ggn_fkSEdXbbtUdv-xAJrE7YxI2WkZHAm8j-FV5REPTXpmv0u7HDaMwqS_7mbl_4Bm3_3TN5JQqOHsNehR_bRu_sRbJh6Hx54PcnlPuycdX_KH8Ov44uQMpRmrdRTunrMqFXD0XjOGCJVdtOSMfmFNZaRMrHfB5nrMkcszVrfP2vYtGaG5A5w78HRZ7cLSQcGjA79mSIxorq5lszJjbPaNFJfLhCgzxkGxHXjxvfXvJZPYDw6uTg-DTsJhlCJIp2H1t2UV9xEaUE8N1j-FUmkcyEiqYQ1yZA0Q6sqK6zIYkESRImMseqwcY7IzvCnsFU3tXkOzEpRpXGlq0RhIGSqIjFAza2NhapSrQJ42zugVB0_OclkXJX-Pzkv0W-l91sAr1e2N56V416rw96PZR9YJSe-ICKxGwbwavUa1xTNmcQ5WsxKhEzEas-LPIBn3u2rYfp4CSBbC4iVAfF1r7-pp98db3eaYjEdZQf__eYL2EU8Vvhu4EPYmrcL8xIxz7wawGY2yfCZjz4PYPvTyfnXbwN3fjBwof4bED4L2g |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Nb9NAEB2VIqAXBIXSQIFFwIGDFce7trMHhFAhpPTjlEq9mfV-iFTUTu1EKPwP_ga_kRmvnbaAuPW8q2zkGc-88c68B_DKDFzMU-WCJHYqEJLrQGFmCIQQynCpcmuaBtmjZHwsPp_EJ2vwq5uFobbKLiY2gdqUmr6R9znxvBD52ODd7Dwg1Si6Xe0kNLxb7NvldyzZ6rd7H9C-r6No9HGyOw5aVYFAC5nMA9cMf2tuw0QSdQtWNDIOzVCIUGnhbDwgGcw8T6UTaSRIVSdWEQJpFw0RrFiOv3sDbgqOmZwm00efLgq8sFGEDYWgfoIk7OhQJe-fVlW_qn6EpF5zOQH-hWr_bM68lO1G9-BuC1PZe-9X92HNFptwywtXLjfh9mF7Jf8Afu5OAkqFhlXKTGnGmVFPSMMXWjOExGxW0WZyAFY6RhLIPuCypp0dQTurfKOuZdOCWdJVwCCHp9fnC0VfJhjdLjBNqkdFeaZYo2vOClsqc7rASmDO0PPOyuZ8P0-2fAjH12KVLVgvysJuA3NK5EmUmzzW6HGpzkl10HDnIqHzxOgevOkMkOmWCJ30OL5l_kKeZ2iszBurBy9Xe2ee_uOfu3Y6O2ZtCKizC4ftwYvVMr689MwUPqNFnSE2I_p8Loc9eOTNvjqGUzKTAlfSKw6x2kDE4FdXiunXhiA8SbBqD9PH__9bz-HOeHJ4kB3sHe0_gQ1EgtL3Ie_A-rxa2KeItub5s8bFGXy57nfqNzL0P7g |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CT-based+radiomic+signatures+for+prediction+of+pathologic+complete+response+in+esophageal+squamous+cell+carcinoma+after+neoadjuvant+chemoradiotherapy&rft.jtitle=Journal+of+radiation+research&rft.au=Yang%2C+Zhining&rft.au=He%2C+Binghui&rft.au=Zhuang%2C+Xinyu&rft.au=Gao%2C+Xiaoying&rft.date=2019-07-01&rft.eissn=1349-9157&rft.volume=60&rft.issue=4&rft.spage=538&rft_id=info:doi/10.1093%2Fjrr%2Frrz027&rft_id=info%3Apmid%2F31111948&rft.externalDocID=31111948 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0449-3060&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0449-3060&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0449-3060&client=summon |